Steroidal Regulation of Cell Cycle Progression
- 28 September 2007
- book chapter
- Published by Wiley
- Vol. 191, 218-234
- https://doi.org/10.1002/9780470514757.ch13
Abstract
Sex steroid hormones and their antagonists have well-defined mitogenic and growth-inhibitory effects on target cells including cancer cells. These effects are mediated by cell cycle phase-specific actions, implying that steroids control rates of cell cycle progression by regulating the expression of key cell cycle regulatory genes. An emerging model of cell cycle control involves transcriptional induction of cyclin genes and consequent activation of cyclin-dependent kinases, which initiate cellular events necessary to complete checkpoints within the cell cycle. Our recent studies have focused on the roles of G1 cyclins, particularly cyclin D1, in the control of cell cycle progression in human breast cancer cells. These studies show that cyclin D1 induction is an early response to mitogenic stimulation by oestrogens and progestins, is rate-limiting for G1 progression and is sufficient for completion of the cell cycle in cells arrested in early G1 phase by serum deprivation. Furthermore, inhibition of cyclin D1 expression is an early response to growth-inhibitory anti-oestrogens. These results suggest that cyclin D1 is a target for regulation of cell cycle progression by sex steroids and their antagonists.Keywords
This publication has 29 references indexed in Scilit:
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Effects of the Progestin Antagonist RU 486 on T-47D Breast Cancer Cell Cycle Kinetics and Cell Cycle Regulatory GenesBiochemical and Biophysical Research Communications, 1993
- Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.Genes & Development, 1993
- Mammalian G1 cyclinsCell, 1993
- Cyclins and oncogenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1993
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Progestin treatment depresses estrogen receptor but not cathepsin D levels in needle aspirates of benign breast diseaseBreast Cancer Research and Treatment, 1991
- Mode of estrogen action on cell proliferation in CAMA‐1 cells: II. Sensitivity of G1 phase populationJournal of Cellular Biochemistry, 1987
- Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycleEuropean Journal of Cancer and Clinical Oncology, 1983
- Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antioestrogensEuropean Journal of Cancer and Clinical Oncology, 1983